EssilorLuxottica

France · www.essilorluxottica.com · 14 vendors

Resilience scores

Technology vendors

Services catalogue

2 services in catalogue across 1 category; runs on 14 sub-vendors.

Insights

Last updated 2026-07-29 · revision 7

14 direct vendors, 229 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 8/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

EssilorLuxottica exhibits high migration readiness (Score: 80). The company's internal tech stack is highly conducive to migration, featuring extensive use of cloud platforms (Microsoft Azure), containerization (Kubernetes, Docker), infrastructure as code (Terraform), and DevOps practices (Azure DevOps). The presence of data platforms like Databricks and Snowflake, and integration tools like MuleSoft, indicates a modern, API-driven architecture that facilitates workload migration. Financially, with substantial and growing revenues (€26.51B in 2024), EssilorLuxottica possesses the resources to fund large-scale migration initiatives. Despite the "Total Vendors: 0" anomaly, the diverse set of enterprise software and cloud services (Microsoft, SAP, Salesforce, ServiceNow, Workday) suggests that many core systems are likely already cloud-based SaaS/PaaS, simplifying their 'migration' to integration or configuration. The use of open-source and cloud-agnostic tools further reduces proprietary vendor lock-in. Challenges include a complex regulatory environment, with GDPR and NIS2 marked as "Assessment Required" and explicit EU data residency requirements. These factors introduce significant planning and execution overhead to ensure data protection, cross-border data transfer compliance, and cybersecurity during any migration. The global scale of operations also presents inherent logistical and coordination challenges.

Compliance

14 in-scope frameworks identified; showing 3.

EU Taxonomy Regulation — Assessment Required

As a large listed EU company, EssilorLuxottica is subject to EU Taxonomy Regulation (2020/852) disclosure requirements, which require reporting on the proportion of turnover, capital expenditure, and operating expenditure aligned with EU Taxonomy environmental objectives. The risk is Medium because: (1) manufacturing companies face complex taxonomy alignment assessments; (2) non-disclosure or inaccurate taxonomy reporting can attract AMF scrutiny; (3) the taxonomy's 'do no significant harm' criteria require detailed supply chain analysis.

Evidence: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32020R0852, https://www.essilorluxottica.com/en/investors/annual-reports/, https://www.amf-france.org/

EU Medical Device Regulation — Compliant

EssilorLuxottica manufactures corrective ophthalmic lenses (prescription lenses, contact lens accessories) which are classified as medical devices under EU MDR 2017/745. Compliance is mandatory for placing products on the EU market. The risk is High because: (1) non-compliance with MDR results in market withdrawal and significant financial impact; (2) MDR requirements are stringent (clinical evaluation, post-market surveillance, Unique Device Identification); (3) the transition from MDD to MDR has been complex for the industry; (4) EssilorLuxottica's core revenue depends on EU market access for optical products. However, as an established market leader, the company is expected to maintain active compliance programs with Notified Bodies.

Evidence: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0745, https://www.essilorluxottica.com/en/brands/, https://ec.europa.eu/health/medical-devices-topics/medical-devices_en, https://eudamed.ec.europa.eu/

Brazil LGPD — Assessment Required

EssilorLuxottica has manufacturing operations in Brazil (Essilor do Brasil) and retail presence through its brands. Brazil's LGPD (effective 2020, enforcement from 2021) applies to any processing of personal data of individuals located in Brazil. The risk is Medium because: (1) ANPD (Brazil's DPA) is increasingly active in enforcement; (2) manufacturing operations involve employee data subject to LGPD; (3) retail operations involve customer data; (4) fines up to 2% of Brazil revenue (capped at R$50 million per violation). The risk is moderated by the fact that LGPD is broadly similar to GDPR, and EssilorLuxottica's GDPR compliance framework can be adapted.

Evidence: https://www.gov.br/anpd/pt-br, https://www.essilorluxottica.com/en/group/, https://www.planalto.gov.br/ccivil_03/_ato2015-2018/2018/lei/l13709.htm

Financials

Three-year financials

Financial Resilience Score: 9/10

EssilorLuxottica demonstrates exceptional financial resilience as the world's largest eyewear and eyecare group, with a vertically integrated business model spanning R&D, lens manufacturing, frames, wholesale, and retail across approximately 18,000 owned stores. The company generates gross margins of ~63-64% and adjusted operating margins of ~16.6%, supported by structural pricing power derived from its dominant market position and iconic brand portfolio including Ray-Ban, Oakley, Persol, and long-term licenses with luxury houses like Chanel, Prada, and Burberry. Financial strength is reinforced by consistent free cash flow generation of €2.5-3.5 billion annually, enabling strategic M&A (GrandVision, Heidelberg Engineering, Supreme, Nuance Audio) while maintaining a conservative balance sheet with net debt/adjusted EBITDA of 1.5-1.8x and investment-grade ratings (A- S&P / A3 Moody's area). Diversification between prescription lenses (non-cyclical medical-adjacent demand) and discretionary sunglasses provides revenue stability across economic cycles. Key risks include discretionary consumer exposure particularly in the U.S. (largest market at ~44% of revenue), ongoing GrandVision integration challenges with regulatory-imposed divestments, FX exposure given euro reporting but significant USD revenue, competition from DTC challengers like Warby Parker, potential loss of key brand licenses, U.S. tariff risk on eyewear imports, and antitrust scrutiny given its dominant market position.

Key strengths: World's largest eyewear/eyecare group with vertical integration across value chain, Approximately 18,000 owned retail stores globally, Gross margins of ~63-64% and adjusted operating margins of ~16.6%, Strong brand portfolio: Ray-Ban, Oakley, Persol, plus luxury licenses (Chanel, Prada, Burberry), Free cash flow generation of €2.5-3.5 billion annually, Investment-grade credit ratings (A- S&P / A3 Moody's area), Net debt/adjusted EBITDA of 1.5-1.8x, Diversification between non-cyclical prescription lenses and discretionary sunglasses

Risk factors: Discretionary consumer exposure particularly in U.S. sunglasses market, GrandVision integration risk with regulatory-imposed divestments in Belgium and Netherlands, FX exposure with euro reporting but significant USD revenue, Competition from DTC online challengers like Warby Parker, Potential loss of key brand licenses, Geopolitical/tariff risk, particularly U.S. tariffs on eyewear imports, Regulatory/antitrust scrutiny given dominant market position, U.S. represents ~44% of revenue creating geographic concentration

Revenue by geography

Revenue by product/service

Workforce by country

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report